Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice

Journal of the Neurological Sciences

Volumn 348, Issue 1-2, 2015, Pages 51-59

  Islam, Fakhrul ^a,c   Javed, Hayate ^a,d   Vaibhav, Kumar ^a,e   Ahmed, M Ejaz ^a   Khan, Andleeb ^a,e   Tabassum, Rizwana ^a   Islam, Farah ^b,c   Safhi, Mohammed M ^c  

^a HAMDARD UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

^c JAZAN UNIVERSITY   (Saudi Arabia)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^e AUGUSTA UNIVERSITY   (United States)

Author keywords

Cognitive impairments; Gangliosides; Hesperidin; Oxidative stress; Phospholipids; Streptozotocin

Indexed keywords

ACETYLCHOLINESTERASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYCLOOXYGENASE 2; GANGLIOSIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HESPERIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; NEUROPROTECTIVE AGENT; PHOSPHOLIPID; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ANTINEOPLASTIC ANTIBIOTIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL DEATH; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; LATENT PERIOD; LIPID BRAIN LEVEL; LIPID METABOLISM; MALE; MEMORY CONSOLIDATION; MOUSE; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED; COGNITION DISORDERS; DRUG EFFECTS; HIPPOCAMPUS; INFLAMMATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BEHAVIOR, ANIMAL; COGNITION DISORDERS; HESPERIDIN; HIPPOCAMPUS; INFLAMMATION; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; OXIDATIVE STRESS; STREPTOZOCIN;

EID: 84920987667     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.10.044     Document Type: Article

References (56)

1. H. Akiyama, S. Barger, S. Barnum, B. Bradt, and J. Bauer Inflammation and Alzheimer's disease Neurobiol Aging 21 2000 383 421
2. A. Brun, and E. Englund Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading Histopathology 5 1981 549 564
3. A. Hayes, U. Thaker, T. Iwatsubo, S. Pickering-Brown, and D. Mann Pathological relationships between microglial cell activity and tau and amyloid β protein in patients with Alzheimer's disease Neurosci Lett 331 2002 171 174
4. M.O. Grimm, J.A. Tschape, H.S. Grimm, E.G. Zinser, and T. Hartmann Altered membrane fluidity and lipid raft composition in presenilin-deficient cells Acta Neurol Scand Suppl 185 2006 27 32
5. T.Y. Mutoh, T. Hirabayashi, M. Mihara, H. Ueda, A. Koga, and T.K. Ueda Role of glycosphingolipids and therapeutic perspectives on Alzheimer's disease CNS Neurol Disord Drug Targets 5 2006 375 380
6. P.B. Crino, M.D. Ullman, B.A. Vogt, E.D. Bird, and L. Volicer Brain gangliosides in dementia of the Alzheimer type Arch Neurol 46 1989 398 401
7. H. Lannert, and S. Hoyer Intracerebroventricular administrationof streptozotocin causes long-term diminutions inlearning and memory abilities and in cerebral energymetabolism in adult rats Behav Neurosci 112 1998 1199 1208
8. M. Sharma, and Y.K. Gupta Chronic treatment with transresveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats Life Sci 71 2002 2489 2498
9. Y. Sun Free radicals, antioxidant enzymes and carcinogenesis Free Radic Biol Med 8 1990 583 599
10. M. Salkovic-Petrisic, F. Tribil, M. Schmidt, S. Hoye, and P. Riedere Alzheimer-like changes of protein kinase band glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway J Neurochem 96 2006 1005 1015
11. E. Grünblatt, M. Salkovic-Petrisic, J. Osmanovic, P. Riederer, and S. Hoyer Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein J Neurochem 10 2007 757 770
12. J. Zhang, R.A. Stanley, L.D. Melton, and M.A. Skinner Inhibition of lipid oxidation by phenolic antioxidants in relation to their physicochemical properties Pharmacologyonline 1 2007 180 189
13. E.M. Galati, M.T. Monforte, S.A. Kirjavainen, M. Forestieri, A. Trovato, and M.M. Tripodo Biological effects of hesperidin, a citrus flavonoid. (Note I): antiinflammatory and analgesic activity Farmaco 40 1994 709 712
14. M.T. Monforte, A. Trovato, S. Kirjavainen, A.M. Forestieri, E.M. Galati, and R.B. Lo Curto Biological effects of hesperidin, a citrus flavonoid. (note II): hypolipidemic activity on experimental hypercholesterolemia in rat Farmaco 50 1995 595 599
15. E.M. Galati, A. Trovato, S. Kirjavainen, A.M. Forestieri, A. Rossitto, and M.T. Monforte Biological effects of hesperidin, a citrus flavonoid. (Note III): antihypertensive and diuretic activity in rat Farmaco 51 1996 219 221
16. T.H. Haines Do sterols reduce proton and sodium leaks through lipid bilayers? Prog Lipid Res 40 2001 299 324
17. S. Bastianetto, Z.X. Yao, and V. Papadopoulos Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity Eur J Neurosci 23 2006 55 64
18. D. Vauzour, G. Ravaioli, and K. Vafeiadou Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols Arch Biochem Biophys 476 2008 145 151
19. L.D. Mercer, B.L. Kelly, and M.K. Horne Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures Biochem Pharmacol 69 2005 339 345
20. R. Morris Development of water maze procedure for studying spatial learning in the rat J Neurosci Methods 11 1984 47 60
21. J. Folch, I. Ascoli, M. Lees, J.A. Meath, and N. LeBaron Preparation of lipide extracts from brain tissue J Biol Chem 191 1951 833 841
22. F. Islam, M. Hasan, R. Rizvi, and S.M. Osman Microanalysis of lipids in discrete brain areas of the rabbit following intramuscular administration of steroid contraceptive Contraception 21 1980 434 442
23. H.G. Utley, F. Bernheim, and P. Hockstein Effect of sulfhydryl reagent on peroxidation in microsome Arch Biochem Biophys 260 1967 521 531
24. F. Islam, S. Zia, I. Sayeed, K.S. Zafar, and A.S. Ahmad Selenium induced alteration on lipids, lipid peroxidation, and thiol group in circadian rhythm centres of rat Biol Trace Elem Res 90 2002 1 12
25. D.J. Jollow, J.R. Mitchell, N. Zampaglione, and J.R. Gillette Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite Pharmacology 11 1974 151 169
26. G.L. Ellman, K.D. Courtney, V.J. Andres, and R.M. Feather-Stone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 1961 88 95
27. S. Pollet, S. Ermidou, F. Le Saux, M. Monge, and N. Baumann Microanalysis of brain lipids: multiple two-dimensional thin-layer chromatography J Lipid Res 19 1978 916 921
28. C.H. Fiske, and Y. Subbarow The colorimetric determination of phosphorus J Biol Chem 66 1925 375 400
29. G.V. Merinetti Chromatographic separation, identification, and analysis of phosphatides J Lipid Res 3 1962 1 20
30. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
31. H. Javed, M.M. Khan, A. Khan, K. Vaibhav, A. Ahmad, and G. Khuwaja S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type Brain Res 1389 2011 133 142
32. S. Tota, P.K. Kamat, R. Shukla, and C. Nath Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment Behav Brain Res 221 2011 207 215
33. P.T. Francis, A.M. Palmer, M. Snape, and G.K. Wilcock The cholinergic hypothesis of Alzheimer's disease: a review of progress J Neurol Neurosurg Psychiatry 66 1999 137 147
34. S. Sonkusare, K. Srinivasan, C. Kaul, and P. Ramarao Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats Life Sci 20 2005 1 14
35. V. Gaur, and A. Kumar Hesperidin pre-treatment attenuates NO-mediated cerebral ischemic reperfusion injury and memory dysfunction Pharmacol Rep 62 2010 635 648
36. R. Liu, I.Y. Liu, X. Bi, R.F. Thompson, S.R. Doctrow, and B. Malfroy Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics Proc Natl Acad Sci U S A 100 2001 8526 8531
37. R. Dringen, J.M. Gutterer, and J. Hirrlinger Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species Eur J Biochem 267 2000 4912 4916
38. A. Meister Glutathione metabolism and its selective modification J Biol Chem 263 1988 1708 17205
39. S. Arlt, U. Beisiegeland, and A. Kontush Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease Curr Opin Lipidol 13 2002 289 294
40. T. Ishrat, M.B. Khan, M.N. Hoda, S. Yusuf, M. Ahmad, and M.A. Ansari Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats Behav Brain Res 171 2006 9 16
41. M.H.V. Kumar, and Y.K. Gupta Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats Clin Exp Pharmacol Physiol 30 2003 336 342
42. N.J. Haughey Sphingolipids in neurodegeneration Neuromolecular Med 12 2010 301 305
43. G.P. Gorbenko, and P.K.J. Kinnunen The role of lipidprotein interactions in amyloid-type protein fibril formation Chem Phys Lipids 141 2006 72 82
44. P.T. Wong, J.A. Schauerte, K.C. Wisser, H. Ding, E.L. Lee, and D.G. Steel Amyloid-β membrane binding and permeabilization are distinct processes influenced separately by membrane charge and fluidity J Mol Biol 386 2009 81 96
45. S. Hakomori Structure, organization, and function of glycosphingolipids in membrane Curr Opin Hematol 10 2003 16 24
46. R.M. Adibhatla, J.F. Hatcher, and R.J. Dempsey Lipids and lipidomics in brain injury and diseases AAPS J 8 2006 E314 E321
47. L. Svennerholmand, and C.G. Gottfries Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II) J Neurochem 62 1994 1039 1047
48. D. Muller, R.M. Nitsch, R.J. Wurtman, and S. Hoyer Streptozotocin increases free fatty acids and decreases phospholipids in rat brain J Neural Transm 105 1998 1271 1281
49. E.G. McGeer, and P.L. McGeer Inflammatory processes in Alzheimer's disease Prog Neuropsychopharmacol Biol Psychiatry 27 2003 741 749
50. L.E. Rojo, J.A. Fernandez, A.A. Maccioni, J.M. Jimenez, and R.B. Maccioni Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease Arch Med Res 39 2008 1 16
51. E.E. Tuppo, and H.R. Arias The role of inflammation in Alzheimer's disease Int J Biochem Cell Biol 37 2005 289 305
52. H. Javed, M.M. Khan, A. Ahmad, and K. Vaibhav Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in ratmodel of sporadic dementia of Alzheimer type Neuroscience 210 2012 340 352
53. A. Parachikova, M.G. Agadjanyan, D.H. Cribbs, M. Blurton-Jones, V. Perreau, and J. Rogers Inflammatory changes parallel the early stages of Alzheimer disease Neurobiol Aging 28 2007 1821 1833
54. T. Wyss-Coray Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12 2006 1005 1015
55. T. Melnikova, A. Savonenko, Q. Wang, X. Liang, T. Hand, and L. Wu Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern Neuroscience 141 2006 1149 1162
56. P. Lu, T. Mamiya, L.L. Lu, A. Mouri, M. Niwa, and M. Hiramatsu Silibinin attenuates amyloid β25-35 peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-K in mice JPET 331 2009 319 326